THAROS™ is a developmental stage company seeking investment via private equity and crowd funding.
Investing in THAROS™ ensures that our unprecedented microbiome research can continue and that the company can reach it’s full potential. Investing in THAROS™ is investing in positive horse healthcare.
THAROS™ is an EIS and SEIS qualifying company.
To find out more, please get in touch with Douglas Dundonald by emailing firstname.lastname@example.org.